Insider Shareholders with Direct Ownership of Decibel Therapeutics, Inc. (DBTX)
This section provides a comprehensive overview of the insiders with direct ownership of Decibel Therapeutics, Inc. (DBTX). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Decibel Therapeutics, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Regeneron Pharmaceuticals, Inc.
> 10% Shareholder |
2,097,314 | 0 | 2,097,314 $0 | 1 |
Feb 17, 2021
Added 50.0%
|
|
Longevity Fund 2 Lp
> 10% Shareholder |
79,143 | 0 | 79,143 $0 | 1 |
Feb 17, 2021
Added 50.0%
|
|
Kevin F Mclaughlin
Director |
5,000 | 5,000 | 0 $0 | 2 |
Sep 25, 2023
Reduced 100.0%
|
|
Matthew C Kapusta
Director |
10,000 | 10,000 | 0 $0 | 2 |
Sep 25, 2023
Reduced 100.0%
|
|
Alison Cecily Finger
Director |
5,000 | 5,000 | 0 $0 | 2 |
Sep 25, 2023
Reduced 100.0%
|
|
William H. Carson
Director |
5,000 | 5,000 | 0 $0 | 2 |
Sep 25, 2023
Reduced 100.0%
|
|
Sara Nochur
Director |
5,000 | 5,000 | 0 $0 | 2 |
Sep 25, 2023
Reduced 100.0%
|
|
Laurence Reid
Director |
205,000 | 220,849 | 0 $0 | 3 |
Sep 25, 2023
Reduced 100.0%
|
|
Anna Trask
Chief People Officer |
105,000 | 123,188 | 0 $0 | 7 |
Sep 25, 2023
Reduced 100.0%
|
|
John Jui Jen Lee
Chief Development Officer |
120,000 | 147,144 | 0 $0 | 2 |
Sep 25, 2023
Reduced 100.0%
|